JP2020109111A - 水性外用剤 - Google Patents
水性外用剤 Download PDFInfo
- Publication number
- JP2020109111A JP2020109111A JP2020042557A JP2020042557A JP2020109111A JP 2020109111 A JP2020109111 A JP 2020109111A JP 2020042557 A JP2020042557 A JP 2020042557A JP 2020042557 A JP2020042557 A JP 2020042557A JP 2020109111 A JP2020109111 A JP 2020109111A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- external preparation
- aqueous external
- aqueous
- acidic drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
表1及び表2に示す組成(重量%)の水性外用剤を調製した。各剤のpHを測定した。また、水性外用剤をガラス容器に充填したときの外観を肉眼で観察した。結果を表1及び2に併せて示す。
外観の評価は以下の基準で行った。
○:澄明な溶液
△:透明な溶液が得られるが経時的に又は振動等の刺激により油相と水相に分離する
調整した水性外用剤及び市販の1%ジクロフェナクナトリウム液剤について、常法に従ってフランツ・セルを用いた皮膚透過性試験を行った。試験にはラット(5週齢、ウィスターラット、雄)の腹部摘出皮膚を用いた。試験開始後2、4、6時間後にサンプリングを行った。6時間後の累積透過量を表1及び2に併せて示す。実施例3、5、11、及び市販の液剤の累積皮膚透過量の推移を表すグラフを図1に示す。
表3に示す組成(重量%)の水性外用剤を調製した。各剤のpHを測定した。また、水性外用剤をガラス容器に充填したときの外観を肉眼で観察した。結果を表3に併せて示す。
外観の評価は以下の基準で行った。
○:澄明な溶液
△:透明な溶液が得られるが経時的に又は振動等の刺激により油相と水相に分離する
表4に示す組成(重量%)のインドメタシンを活性成分として含む水性外用剤を調製した。各剤のpHを測定した。また、水性外用剤をガラス容器に充填したときの外観を肉眼で観察した。結果を4に示す。
外観の評価は以下の基準で行った。
○:澄明な溶液
Claims (5)
- 酸性薬物又はその塩と、イソステアリン酸、アルカノールアミン、イソプロパノール、及びプロピレングリコールを含む水性外用剤であって、イソプロパノール及びプロピレングリコールの低級アルコールを1:3〜3:1 (イソプロパノール:プロピレングリコール)の割合で含む、水性外用剤。
- さらに、C2−6脂肪族ヒドロキシ酸を含み、pHが4.5〜7.8である、請求項1に記載の水性外用剤。
- 上記C2−6脂肪族ヒドロキシ酸が、乳酸、グリコール酸、リンゴ酸、酒石酸、クエン酸から成る群より選択される1種又は2種以上の組み合わせである、請求項1又は2に記載の水性外用剤。
- 上記酸性薬物が、アリール酢酸系非ステロイド性消炎鎮痛剤である、請求項1〜3のいずれか一項に記載の水性外用剤。
- さらに、グリセリンを含む、請求項1〜4のいずれか一項に記載の水性外用剤。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015016365 | 2015-01-30 | ||
JP2015016365 | 2015-01-30 | ||
JP2015110902 | 2015-05-29 | ||
JP2015110902 | 2015-05-29 | ||
JP2016572213A JP6676548B2 (ja) | 2015-01-30 | 2016-01-29 | 水性外用剤 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016572213A Division JP6676548B2 (ja) | 2015-01-30 | 2016-01-29 | 水性外用剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020109111A true JP2020109111A (ja) | 2020-07-16 |
JP6956426B2 JP6956426B2 (ja) | 2021-11-02 |
Family
ID=56543598
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016572213A Active JP6676548B2 (ja) | 2015-01-30 | 2016-01-29 | 水性外用剤 |
JP2020042557A Active JP6956426B2 (ja) | 2015-01-30 | 2020-03-12 | 水性外用剤 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016572213A Active JP6676548B2 (ja) | 2015-01-30 | 2016-01-29 | 水性外用剤 |
Country Status (6)
Country | Link |
---|---|
US (2) | US11090265B2 (ja) |
EP (1) | EP3251695A4 (ja) |
JP (2) | JP6676548B2 (ja) |
CN (1) | CN107148284A (ja) |
BR (1) | BR112017016010B1 (ja) |
WO (1) | WO2016121996A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6676548B2 (ja) * | 2015-01-30 | 2020-04-08 | 株式会社 メドレックス | 水性外用剤 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991012821A1 (en) * | 1990-03-02 | 1991-09-05 | Shiseido Company, Ltd. | Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
WO1996004902A1 (fr) * | 1994-08-09 | 1996-02-22 | Tsumura & Co. | Composition pour preparation a usage externe |
WO2004064817A1 (ja) * | 2003-01-22 | 2004-08-05 | Nichiban Co., Ltd. | 眼疾患治療用経皮吸収型製剤、その使用、及び眼疾患治療薬の眼の局所組織への移行方法 |
JP2009519958A (ja) * | 2005-12-14 | 2009-05-21 | ザーズ, インコーポレイテッド | 薬物の皮膚送達のための、フラックス化可能な組成物および方法 |
JP2009519940A (ja) * | 2005-12-14 | 2009-05-21 | ザーズ, インコーポレイテッド | 皮膚科学的状態を処置するための組成物および方法 |
JP2009519956A (ja) * | 2005-12-14 | 2009-05-21 | ザーズ, インコーポレイテッド | 薬物の皮膚送達のための組成物および方法 |
WO2010103844A1 (ja) * | 2009-03-11 | 2010-09-16 | 興和株式会社 | 鎮痛・抗炎症剤含有外用剤 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61280426A (ja) | 1985-06-04 | 1986-12-11 | Ikeda Mohandou:Kk | 消炎鎮痛用貼付剤 |
JP2523428B2 (ja) | 1992-12-04 | 1996-08-07 | エスエス製薬株式会社 | 消炎鎮痛ゲル製剤 |
US6054484A (en) | 1996-02-07 | 2000-04-25 | Tsumura & Co. | Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
JP4275751B2 (ja) | 1996-12-27 | 2009-06-10 | 久光製薬株式会社 | 外用組成物 |
US6455067B1 (en) * | 2000-05-24 | 2002-09-24 | Sang-A Pharmaceutical Co., Ltd. | Transdermal patch for nonsteroidal antiinflammatory drug(s) |
JP4820065B2 (ja) | 2004-05-24 | 2011-11-24 | 同仁医薬化工株式会社 | 消炎鎮痛外用水性液剤 |
CN101909651B (zh) * | 2007-11-22 | 2013-11-06 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
HUP0700828A2 (en) * | 2007-12-20 | 2010-01-28 | Richter Gedeon Nyrt | Transdermal pharmaceutical compositions containing tolperisone alone and in combination |
US20100099766A1 (en) * | 2008-10-16 | 2010-04-22 | Novartis Ag | Topical NSAID compositions having sensate component |
JP2014101338A (ja) | 2012-11-22 | 2014-06-05 | Japan Medic Kk | 消炎鎮痛外用薬剤 |
JP6060742B2 (ja) | 2013-03-08 | 2017-01-18 | ライオン株式会社 | 外用液体組成物 |
JP6738120B2 (ja) | 2013-03-29 | 2020-08-12 | 小林製薬株式会社 | 外用医薬組成物 |
JP6676548B2 (ja) * | 2015-01-30 | 2020-04-08 | 株式会社 メドレックス | 水性外用剤 |
-
2016
- 2016-01-29 JP JP2016572213A patent/JP6676548B2/ja active Active
- 2016-01-29 EP EP16743599.9A patent/EP3251695A4/en active Pending
- 2016-01-29 CN CN201680006476.3A patent/CN107148284A/zh active Pending
- 2016-01-29 BR BR112017016010-2A patent/BR112017016010B1/pt active IP Right Grant
- 2016-01-29 WO PCT/JP2016/052838 patent/WO2016121996A1/ja active Application Filing
- 2016-01-29 US US15/546,798 patent/US11090265B2/en active Active
-
2020
- 2020-03-12 JP JP2020042557A patent/JP6956426B2/ja active Active
-
2021
- 2021-07-21 US US17/382,272 patent/US20210353539A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991012821A1 (en) * | 1990-03-02 | 1991-09-05 | Shiseido Company, Ltd. | Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
WO1996004902A1 (fr) * | 1994-08-09 | 1996-02-22 | Tsumura & Co. | Composition pour preparation a usage externe |
WO2004064817A1 (ja) * | 2003-01-22 | 2004-08-05 | Nichiban Co., Ltd. | 眼疾患治療用経皮吸収型製剤、その使用、及び眼疾患治療薬の眼の局所組織への移行方法 |
JP2009519958A (ja) * | 2005-12-14 | 2009-05-21 | ザーズ, インコーポレイテッド | 薬物の皮膚送達のための、フラックス化可能な組成物および方法 |
JP2009519940A (ja) * | 2005-12-14 | 2009-05-21 | ザーズ, インコーポレイテッド | 皮膚科学的状態を処置するための組成物および方法 |
JP2009519956A (ja) * | 2005-12-14 | 2009-05-21 | ザーズ, インコーポレイテッド | 薬物の皮膚送達のための組成物および方法 |
WO2010103844A1 (ja) * | 2009-03-11 | 2010-09-16 | 興和株式会社 | 鎮痛・抗炎症剤含有外用剤 |
Also Published As
Publication number | Publication date |
---|---|
JP6956426B2 (ja) | 2021-11-02 |
JPWO2016121996A1 (ja) | 2017-11-09 |
US20180015037A1 (en) | 2018-01-18 |
US20210353539A1 (en) | 2021-11-18 |
EP3251695A4 (en) | 2018-08-01 |
EP3251695A1 (en) | 2017-12-06 |
BR112017016010A2 (ja) | 2018-03-20 |
US11090265B2 (en) | 2021-08-17 |
BR112017016010B1 (pt) | 2023-02-14 |
JP6676548B2 (ja) | 2020-04-08 |
CN107148284A (zh) | 2017-09-08 |
WO2016121996A1 (ja) | 2016-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5704367B2 (ja) | 脂肪酸系イオン液体を有効成分とする外用剤組成物 | |
CA2818891C (en) | Topical ibuprofen formulations | |
JP5351518B2 (ja) | 外用医薬組成物及び貼付剤 | |
ES2503215T3 (es) | Parche adhesivo analgésico antiinflamatorio para uso externo | |
JP4526598B2 (ja) | 乳化型外用剤およびその製造方法 | |
JP2001513543A (ja) | 皮膚への局所適用のための非ステロイド性抗炎症薬製剤 | |
JP5421063B2 (ja) | ジクロフェナクナトリウム含有水性貼付剤 | |
JP2020109111A (ja) | 水性外用剤 | |
WO2005112909A1 (ja) | 消炎鎮痛外用水性液剤 | |
JP5681883B2 (ja) | 核酸を有効成分とする外用剤組成物 | |
JP5836561B2 (ja) | 皮膚外用剤 | |
JP7045045B2 (ja) | 外用剤 | |
JP2015214580A (ja) | 皮膚外用剤 | |
JP6322169B2 (ja) | 皮膚外用剤 | |
JP5578778B2 (ja) | 皮膚外用剤 | |
WO2019059376A1 (ja) | 6-デオキシ-7,8-ジヒドロ-6-オキソモルヒネ骨格を有する化合物を薬効成分とする外用剤組成物 | |
JP2014101385A (ja) | 皮膚外用剤 | |
JP2018052902A (ja) | 水性固形軟膏 | |
JP2014129424A (ja) | 皮膚外用剤 | |
JP2014156481A (ja) | 核酸を有効成分とする外用剤組成物 | |
JP2010083819A (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200312 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210201 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210329 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210514 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210903 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210914 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210928 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6956426 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |